Episode 3 - The Future is Now

This episode's guest: Dr. Ajit Singh

Ajit Singh has had a vast variety of experiences in digital pathology as well as digital radiology - in both operations and venture capital. He was President and CEO at BioImagene, a digital pathology company which was acquired by Roche and CEO of digital radiology and medical informatics at Siemens healthcare.

He is a partner at Artiman Ventures, focusing on early stage Technology and life sciences investments. Dr. Singh also serves as adjunct professor at the Stanford University School of Medicine, and is on the Board of Trustees of the AACR.

He joins us to talk about similarities and differences between the two visually based diagnostic specialties, pathology and radiology, challenges and opportunities as it applies to the global workforce shortage of pathologists in both the developed and developing world , as well as practical applications of artificial intelligence in digital pathology, and why the future might be here sooner than you may think.


More About Dr. Ajit Singh

Ajit Singh is a partner at Artiman Ventures, a Silicon Valley VC firm focused on early-stage technology and life science investments. He also serves on the board of Trustees of the American Association for Cancer Research (AACR) Foundation and is an Adjunct Professor in the School of Medicine at Stanford. He is on the Board of Directors of Visby Medical, CORE Diagnostics, Cadila Pharmaceuticals, Summer Bio and Sofie Biosciences, and is a Senior Advisor to the Tata Trusts Cancer Care program.

In the past he has served as the CEO of Siemens Oncology and the CEO of BioImagene, a cancer diagnostics startup that was acquired by Roche. Ajit has a Ph.D. in Computer Science from Columbia University, a Master’s in Computer Engineering from Syracuse University and a bachelor’s in Electrical Engineering from Banaras Hindu University. He has published two books and five patents.